Cannabis is listed as a narcotic under Schedule I of the Law on Procedures for Legal Trade in Narcotic and Psychotropic Substances and Medicines (Narcotics Act). This includes cannabis resin, oil, extracts and tinctures of cannabis as well as leaves. The list of controlled substances is included in Law on the procedure for entry into force and application of the Criminal Code.
This report provides a detailed overview of Latvia’s regulatory framework for CBD and cannabis, as well as other minor cannabinoids, covering all policy areas from cultivation and extracts to finished products and import/export.
Laura holds a Master’s degree in Public Law from the University of Seville, Spain, where she mainly specialised in International Law and Administrative Law. She has also studied International and European Law at the University of Helsinki, Finland, under the Erasmus Programme.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
LATEST ALERTS
